Allianz Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.19M Buy
83,000
+3,700
+5% +$354K 0.01% 1003
2025
Q4
$7.62M Buy
79,300
+18,500
+30% +$1.8M 0.01% 950
2025
Q3
$5.79M Sell
60,800
-22,900
-27% -$2.11M 0.01% 1046
2025
Q2
$7.3M Sell
83,700
-1,600
-2% -$136K 0.01% 933
2025
Q1
$7.67M Buy
85,300
+22,300
+35% +$2M 0.01% 895
2024
Q4
$5.03M Sell
63,000
-2,200
-3% -$190K 0.01% 1042
2024
Q3
$5.87M Buy
65,200
+29,700
+84% +$2.5M 0.01% 964
2024
Q2
$2.79M Buy
35,500
+32,400
+1,045% +$2.66M ﹤0.01% 1188
2024
Q1
$270K Sell
3,100
-45,200
-94% -$3.86M ﹤0.01% 1784
2023
Q4
$3.98M Sell
48,300
-71,100
-60% -$5.42M 0.01% 1032
2023
Q3
$9.36M Buy
119,400
+60,600
+103% +$5.07M 0.02% 745
2023
Q2
$5.18M Sell
58,800
-17,700
-23% -$1.52M 0.01% 854
2023
Q1
$6.17M Sell
76,500
-13,000
-15% -$1.06M 0.01% 889
2022
Q4
$6.96M Buy
89,500
+3,400
+4% +$276K 0.01% 802
2022
Q3
$6.95M Buy
86,100
+48,300
+128% +$4.34M 0.01% 767
2022
Q2
$3.39M Sell
37,800
-26,600
-41% -$2.7M ﹤0.01% 1239
2022
Q1
$7.14M Buy
64,400
+33,100
+106% +$3.5M 0.01% 1095
2021
Q4
$3.24M Sell
31,300
-86,400
-73% -$10M ﹤0.01% 1412
2021
Q3
$14.8M Buy
117,700
+80,700
+218% +$10.4M 0.01% 851
2021
Q2
$4.59M Sell
37,000
-20,600
-36% -$2.59M ﹤0.01% 1158
2021
Q1
$6.8M Buy
+57,600
New +$6.75M 0.01% 958
2020
Q1
Sell
-296,000
Closed -$33.6M 2648
2019
Q4
$33.6M Buy
296,000
+24,400
+9% +$2.68M 0.03% 554
2019
Q3
$29.5M Sell
271,600
-33,600
-11% -$3.51M 0.03% 626
2019
Q2
$29.7M Buy
305,200
+87,400
+40% +$7.98M 0.03% 628
2019
Q1
$19.8M Sell
217,800
-201,600
-48% -$18M 0.02% 759
2018
Q4
$38.1M Sell
419,400
-104,300
-20% -$9.75M 0.04% 445
2018
Q3
$51.5M Sell
523,700
-96,600
-16% -$8.93M 0.05% 423
2018
Q2
$53.1M Buy
620,300
+23,600
+4% +$1.97M 0.05% 386
2018
Q1
$47.9M Sell
596,700
-1,016,700
-63% -$83.9M 0.05% 446
2017
Q4
$130M Buy
1,613,400
+128,500
+9% +$10.3M 0.1% 238
2017
Q3
$115M Buy
1,484,900
+376,000
+34% +$31.2M 0.1% 243
2017
Q2
$98.4M Buy
1,108,900
+254,100
+30% +$21.4M 0.09% 249
2017
Q1
$68.9M Sell
854,800
-2,042,300
-70% -$160M 0.07% 349
2016
Q4
$206M Buy
2,897,100
+653,800
+29% +$51.4M 0.18% 110
2016
Q3
$194M Buy
2,243,300
+1,148,500
+105% +$100M 0.19% 110
2016
Q2
$95M Buy
1,094,800
+487,200
+80% +$39.4M 0.1% 219
2016
Q1
$45.6M Buy
+607,600
New +$45.8M 0.05% 412
2015
Q1
Sell
-365,100
Closed -$26.4M 2307
2014
Q4
$26.4M Buy
365,100
+220,500
+152% +$15.3M 0.03% 615
2014
Q3
$8.96M Buy
+144,600
New +$9.19M 0.01% 868

Other funds holding MDT

Allianz Asset Management's MDT Position: Q1 2026 in Review

Allianz Asset Management reduced its Medtronic (MDT) stake by 18% in Q1 2026, selling an estimated $31.4M and leaving 1,519,301 shares worth $132M. The position accounts for 0.14% of the portfolio, ranked #144.

Allianz Asset Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $437M in Q3 2013. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Allianz Asset Management held 1,519,301 shares of Medtronic worth $132M as of Q1 2026.
  • Allianz Asset Management sold 327,582 Medtronic shares in Q1 2026, an estimated $31.4M.
  • Medtronic made up 0.14% of Allianz Asset Management's portfolio in Q1 2026, its #144 holding.
  • Allianz Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Allianz Asset Management's Medtronic position peaked at $437M in Q3 2013.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.